Evidence map›Paper›PMID 27543159›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation.

Raimon Duran-Struuck, Abraham J Matar, Rebecca L Crepeau, Alexander G S Teague, Benjamin M Horner, Vimukthi Pathiraja, Thomas R Spitzer, Jay A Fishman, Roderick T Bronson, David H Sachs and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Raimon Duran-StruuckDepartment of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts. Electronic address: Rduranst@gmail.com.
Abraham J MatarMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts; College of Medicine, University of Central Florida, Orlando, Florida.
Rebecca L CrepeauMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Alexander G S TeagueMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Benjamin M HornerMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Vimukthi PathirajaMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Thomas R SpitzerBone Marrow Transplant Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Jay A FishmanMassachusetts General Hospital, MGH Transplantation Center and Transplant Infectious Disease & Compromised Host Program, Boston, Massachusetts.
Roderick T BronsonDepartment of Pathology, Harvard Medical School, Boston, Massachusetts.
David H SachsMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Christene A HuangMassachusetts General Hospital, Transplantation Biology Research Center, Boston, Massachusetts.
Massachusetts General Hospital · USHarvard University · USUniversity of Pennsylvania · US

Funding

Elucidating the role of T-regs in engraftment, GVHD, and DLI immunotherapyR01AI084657 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, CHRISTENE A · 2009 to 2013
$2.3M
NIAID NIH HHS R01 AI084657
6 · The paper itself

Abstract

We previously described successful hematopoietic stem cell engraftment across MHC barriers in miniature swine without graft-versus-host disease (GVHD) using novel reduced-intensity conditioning regimens consisting of partial transient recipient T cell-depletion, thymic or low-dose total body irradiation, and a short course of cyclosporine A. Here we report that stable chimeric animals generated with these protocols are strongly resistant to donor leukocyte infusion (DLI)-mediated GVH effects. Of 33 total DLIs in tolerant chimeras at clinical doses, 21 failed to induce conversion to full donor hematopoietic chimerism or cause GVHD. We attempted to overcome this resistance to conversion through several mechanisms, including using sensitized donor lymphocytes, increasing the DLI dose, removing chimeric host peripheral blood cells through extensive recipient leukapheresis before DLI, and using fully mismatched lymphocytes. Despite our attempts, the resistance to conversion in our model was robust, and when conversion was achieved, it was associated with GVHD in most animals. Our studies suggest that delivery of unmodified hematopoietic stem cell doses under reduced-intensity conditioning can induce a potent, GVHD-free, immune tolerant state that is strongly resistant to DLI.

Indexed as

Blood DonorsAnimalsCyclosporineGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLymphocyte DepletionLymphocyte TransfusionSwineTransplantation ChimeraTransplantation ConditioningTransplantation, HaploidenticalWhole-Body IrradiationCyclosporineDonor leukocyte infusionGraft-versus-leukemia and graft-versus-host diseaseLymphohematopoietic graft-versus- host responsesMHC defined miniature swineMixed chimerism

Identifiers

PMID27543159
PMCPMC6994166
OpenAlexW2517223598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.